You are here!

In the city of Milan

With experts in biomaterials development for healthcare and aesthetic products

Welcome to BMG Pharma

BMG is a cutting-edge company with years of experience in the development and international partnership of biopharmaceutical products.

The final goals of other companies are just starting points for us.

We believe that transparency
is a fundamental value.

PR FESR 2021-27 – Research and Development Call 2022

PR FESR 2021-27 – Research and Development Call 2022

DEVELOPMENT OF INNOVATIVE BIOMATERIALS USEFUL IN REGENERATIVE MEDICINE BASED ON BIOCOMPATIBLE DERIVATIVES OF SODIUM HYALURONATE WITH BIOLOGICALLY ACTIVE FUNCTIONS. Beneficiary: BMG Pharma® SpA Eligible expenditure: 739.625,51 Euro Grant granted: 313.899,64 Euro ...

The latest news

Mastrodonato (BMG Pharma): without innovation you cannot be successful

Mastrodonato (BMG Pharma): without innovation you cannot be successful

Are you interested in knowing the point of view of our founder and CEO Marco Mastrodonato about how to do pharmaceutical entrepreneurship?

Read his interview on Caltalks:
“Thinking outside the box”, innovation as secret of the success.
BMG Pharma performs the concept of innovation in the biotech sector, relying on chemical structure modification of biotechnological origin for the development of new chemical entities and improving their functions and efficacy, differentiating itself from all competitors on the market. “Our strategy,” Mastrodonato continues, “is to develop biotechnology products covering both aesthetic dermatology and osteoarthritis.”
In BMG Pharma we find not limits, but solutions, the company wants to be present in the market bringing new products based on science and aligning itself with an evolving context, trying to deliver in the hands of the physician something truly innovative, interactive, and effective to propose to the patient.

To read the whole interview, click here: https://www.caltalks.com/2023/11/mastrodonato-bmg-pharma-senza.html

The latest news

PR FESR 2021-27 – Research and Development Call 2022

PR FESR 2021-27 – Research and Development Call 2022

DEVELOPMENT OF INNOVATIVE BIOMATERIALS USEFUL IN REGENERATIVE MEDICINE BASED ON BIOCOMPATIBLE DERIVATIVES OF SODIUM HYALURONATE WITH BIOLOGICALLY ACTIVE FUNCTIONS. Beneficiary: BMG Pharma® SpA Eligible expenditure: 739.625,51 Euro Grant granted: 313.899,64 Euro ...

Mastrodonato (BMG Pharma): without innovation you cannot be successful

Mastrodonato (BMG Pharma): without innovation you cannot be successful

Are you interested in knowing the point of view of our founder and CEO Marco Mastrodonato about how to do pharmaceutical entrepreneurship?

Read his interview on Caltalks:
“Thinking outside the box”, innovation as secret of the success.
BMG Pharma performs the concept of innovation in the biotech sector, relying on chemical structure modification of biotechnological origin for the development of new chemical entities and improving their functions and efficacy, differentiating itself from all competitors on the market. “Our strategy,” Mastrodonato continues, “is to develop biotechnology products covering both aesthetic dermatology and osteoarthritis.”
In BMG Pharma we find not limits, but solutions, the company wants to be present in the market bringing new products based on science and aligning itself with an evolving context, trying to deliver in the hands of the physician something truly innovative, interactive, and effective to propose to the patient.

To read the whole interview, click here: https://www.caltalks.com/2023/11/mastrodonato-bmg-pharma-senza.html